首頁 > 市場調查報告書 > 醫療設備

整形外科

人工肌腱和韌帶市場規模、佔有率和成長分析（按植入類型、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1896000

人工肌腱和韌帶市場規模、佔有率和成長分析（按植入類型、應用、最終用戶和地區分類）—2026-2033年產業預測

Artificial Tendons And Ligaments Market Size, Share, and Growth Analysis, By Implant Type (Silastic-rod implant, Marlex mesh), By Application (Knee Injuries, Shoulder Injuries), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球人工肌腱和韌帶市場規模預計在 2024 年達到 126.1 億美元，從 2025 年的 143.2 億美元成長到 2033 年的 397.3 億美元，在預測期（2026-2033 年）內複合年成長率為 13.6%。

受微創手術需求不斷成長以及人們對運動傷害的認知日益提高的推動，全球人工肌腱和韌帶市場正經歷顯著成長。這些合成植入的研發關鍵在於性能、設計、材料選擇以及透過臨床前和臨床試驗進行的全面評估，重點在於機械負荷和疲勞測試。傳統植入手術的併發症，例如斷裂和膝關節不適，促使人們對合成替代方案產生了濃厚的興趣。持續的研發工作旨在創造兼具高抗張強度和組織相容性的創新材料。尤其是在生物工程領域，一些前景廣闊的進展有望改善植入的功能和生物整合性，從而進一步推動市場成長，因為相關人員正在尋求用於有效韌帶修復的更優材料。

全球人工肌腱和韌帶市場促進因素

推動全球人工肌腱和韌帶市場發展的關鍵因素之一是運動傷害發生率的不斷上升。這些損傷通常由多種因素引起，包括意外事故、技術不當、熱身和拉伸不足以及體能訓練不足。運動員會經歷各種各樣的損傷，例如網球肘、踝關節扭傷、鼠蹊部拉傷、膕繩肌拉傷和前十字韌帶 (ACL)斷裂。人們對這些損傷的認知不斷提高，對有效治療方法的需求日益成長，推動了市場的發展，個人和醫療保健機構都在尋求創新的解決方案來應對這些挑戰。

全球人工肌腱和韌帶市場阻礙因素

研發成本的不斷攀升預計將阻礙全球人工肌腱和韌帶市場的成長。此外，該市場在不久的將來可能面臨安全性和合規性方面的挑戰。這些因素可能成為該領域企業發展的障礙，阻礙創新和新產品上市。為了應對這種複雜的市場環境，企業可能需要投入大量資源來確保安全標準並遵守監管要求，最終可能會影響其整體市場表現和擴張潛力。

全球人工肌腱和韌帶市場趨勢

全球人工肌腱和韌帶市場正呈現顯著的膝關節損傷治療趨勢，這主要受運動參與度提高以及膝關節損傷發生率上升的推動。由於人工修復具有恢復時間短、可得性等諸多優勢，患者越來越傾向於選擇人工修復方案而非傳統的異體移植手術。人工韌帶手術效率更高，例如手術時間比自體移植更短，這進一步提升了其吸引力。隨著醫療技術的進步和意識提升，預計該細分市場對膝關節損傷治療創新解決方案的需求將進一步增強。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Smith+Nephew（United Kingdom）
Zimmer Biomet（United States）
Xiros Ltd.（Neoligaments）（United Kingdom）
Orthomed SAS（France）
Shanghai PINE&POWER Biotech（China）
Arthrex Inc.（United States）
Corin Group（United Kingdom）
Enovis Corporation（Mathys AG Bettlach）（Switzerland）
Stryker Corporation（United States）
GROUP FH ORTHO（France）
FX Solutions（France）
LARS（Corin Group）（France）
Cousin Biotech（France）
Mathys AG Bettlach（Switzerland）
Ossur hf（Iceland）
Integra LifeSciences Holdings Corporation（United States）
Medtronic plc（Ireland）
Orthonika, Inc.（United Kingdom）
United Orthopedic Corporation（Taiwan）

結論與建議

簡介目錄

Product Code: SQMIG35J2093

Global Artificial Tendons And Ligaments Market size was valued at USD 12.61 Billion in 2024 and is poised to grow from USD 14.32 Billion in 2025 to USD 39.73 Billion by 2033, growing at a CAGR of 13.6% during the forecast period (2026-2033).

The global market for artificial tendons and ligaments is experiencing significant growth driven by rising demand for minimally invasive surgical procedures and increased awareness of sports-related injuries. Key considerations in the development of these synthetic implants include performance, design, material selection, and thorough evaluation through pre-clinical and clinical studies, focusing on mechanical loads and fatigue testing. Complications from traditional graft surgeries, such as tendon rupture and knee discomfort, have amplified interest in synthetic alternatives. Ongoing R&D efforts aim to produce innovative materials that exhibit high tensile strength and compatibility with natural tissues. Promising advancements, particularly in bioengineering, are poised to enhance implant functionality and integration, further propelling market growth as stakeholders explore superior materials for effective ligament restoration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Tendons And Ligaments market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Tendons And Ligaments Market Segments Analysis

Global Artificial Tendons And Ligaments Market is segmented by Implant Type, Application, End User and region. Based on Implant Type, the market is segmented into Silastic-rod implant, Marlex mesh, Carbon-Fibre implant and Others. Based on Application, the market is segmented into Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgery Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Tendons And Ligaments Market

A significant factor driving the Global Artificial Tendons and Ligaments market is the increasing incidence of sports injuries. These injuries often result from various factors including accidents, improper techniques, insufficient warm-up and stretching practices, as well as inadequate physical conditioning. Athletes commonly experience a range of these injuries, including conditions such as tennis elbow, ankle sprains, groin pulls, hamstring strains, and tears of the anterior cruciate ligament (ACL). The growing awareness of these injuries and the associated demand for effective treatment options are propelling the market forward, as individuals and healthcare providers seek innovative solutions to address these challenges.

Restraints in the Global Artificial Tendons And Ligaments Market

Increasing expenses associated with research and development are anticipated to hinder the growth of the Global Artificial Tendons and Ligaments market. Additionally, the market is likely to encounter challenges related to safety and regulatory compliance in the near future. These factors may create obstacles for companies operating within this sector, complicating their capacity to innovate and bring new products to market. As organizations navigate these complexities, they may need to allocate significant resources toward ensuring safety standards and meeting regulatory requirements, which could ultimately impact their overall market performance and expansion potential.

Market Trends of the Global Artificial Tendons And Ligaments Market

The Global Artificial Tendons and Ligaments market showcases a significant trend towards the knee injuries segment, driven by increasing sports participation and the corresponding rise in knee injury incidences. Patients tend to prefer artificial solutions over traditional surgical treatments using allografts due to various advantages such as reduced recovery times and improved availability. The operational efficiency associated with artificial ligaments, including quicker procedure times compared to donor grafts, further bolsters their appeal. As healthcare technologies advance and patient awareness grows, the demand for innovative solutions in managing knee injuries is expected to strengthen within this market segment.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Artificial Tendons And Ligaments Market Size by Implant Type & CAGR (2026-2033)

Market Overview
Silastic-rod implant
Marlex mesh
Carbon-Fibre implant
Others

Global Artificial Tendons And Ligaments Market Size by Application & CAGR (2026-2033)

Market Overview
Knee Injuries
Shoulder Injuries
Foot & Ankle Injuries
Spine Injuries
Hip Injuries
Others

Global Artificial Tendons And Ligaments Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Ambulatory Surgery Centres
Others

Global Artificial Tendons And Ligaments Market Size & CAGR (2026-2033)

North America (Implant Type, Application, End User)
- US
- Canada
Europe (Implant Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Implant Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Implant Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Implant Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Smith+Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xiros Ltd. (Neoligaments) (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthomed S.A.S. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai PINE&POWER Biotech (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corin Group (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enovis Corporation (Mathys AG Bettlach) (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GROUP FH ORTHO (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FX Solutions (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LARS (Corin Group) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cousin Biotech (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mathys AG Bettlach (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossur hf (Iceland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthonika, Inc. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
United Orthopedic Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments